You are warmly invited to the Inaugural Lecture of Professor Hans Michael Haitchi in the Faculty of Medicine.
Title: “From Austria to “Angleterre” – My Journey from Asthma to ADAM33”
Date: Thursday 8 May 2025
Venue: Online / IDS Lecture Theatre, 天发娱乐棋牌_天发娱乐APP-官网|下载 General Hospital
Timing: Lecture from 17:15
About the event
Hans Michael Haitchi is Professor of Respiratory Medicine and an Academic Clinician Scientist at the University of 天发娱乐棋牌_天发娱乐APP-官网|下载, as well as an Honorary Consultant Physician at University Hospital 天发娱乐棋牌_天发娱乐APP-官网|下载 NHS Foundation Trust.
Trained in Austria, South Africa, the UK, and the USA, he leads a research group investigating the mechanisms underlying asthma and chronic lung diseases. His work focuses on the asthma susceptibility gene ADAM33 and how the maternal environment influences early lung disease development. He also treats and studies patients with difficult-to-treat asthma while exploring novel Anti-ADAM33 therapies as potential disease-modifying treatments.
Professor Haitchi’s research is based in the School of Clinical & Experimental Sciences (CES) at the Faculty of Medicine and the NIHR 天发娱乐棋牌_天发娱乐APP-官网|下载 Biomedical Research Centre’s Respiratory Theme, where he is a principal investigator. Working with national and international collaborators, his work bridges laboratory research and clinical applications, aiming to improve understanding and treatment of asthma to enhance patient outcomes.
Synopsis of presentation
In this inaugural lecture, Professor Haitchi shares his personal and academic research journey, exploring the key milestones that shaped his career as academic clinician scientist in respiratory medicine and asthma research. Trained in Austria, South Africa, the UK, and the United States of America, he reflects on the inspirations and challenges that led him to focus on asthma and chronic lung diseases.
The lecture delves into his pioneering work on ADAM33, an asthma susceptibility gene, and how it contributes to airway remodelling and disease progression. He further explores the role of the maternal environment in early lung disease development, difficult-to-treat adult asthma and the potential of Anti-ADAM33 therapies as novel disease-modifying asthma therapy.
Looking ahead, Professor Haitchi discusses the future of respiratory medicine, and in particular asthma, highlighting the impact of genetics, AI, and digital health in advancing diagnosis and treatment. Concluding with a vision for collaborative asthma research, he calls on clinicians, scientists, and policymakers to work together to improve asthma patient outcomes. This may lead to the next breakthroughs needed in asthma research.
Please note there are two types of ticket available for this event, in person admission or online. However, registration for in person tickets has already closed.
Register for the online event?here. Online registration closes at 15.00 on Wednesday 7 May 2025. ?A link to access the online event will be sent to those registered the day before the event.
Please email medevent@soton.ac.uk with any queries.